Spironolactone (aldosterone/mineralocorticoid receptor antagonist)

Well-done! Spironolactone, an aldosterone antagonist, has been shown to decrease the progression of heart failure, most likely due to reduced remodeling, diminished endothelial dysfunction and reduced arrhythmogenesis.

The cardiologist goes on to explain that while spironolactone is a beneficial drug, studies have shown some potential adverse effects. He further explains that it is important to watch out for these effects through certain tests. The cardiologist looks over to you. 

Which test should be used to monitor safety of this drug?

  • Serum testosterone
  • Serum potassium
  • Glomerular filtration rate
  • Serum sodium

Map: Faith Reed_ORU_1 (1090)
Node: 20600
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Oral prednisolone (glucocorticoid)
  • Intravenous resluzimab (IL-5 antibody)
  • Oral prednisolone
  • Ask the patient to take a clear photo of the wound (10–15 cm distance, adequate lighting) and upload it to the app
  • Nebulized ipratropium (SAMA, anticholinergic)
  • Intravenous resluzimab
  • Spironolactone (aldosterone/mineralocorticoid receptor antagonist)

Reminder

FINISH

Time is up